VSIQQ Trademark

Trademark Overview


On Thursday, May 20, 2021, a trademark application was filed for VSIQQ with the United States Patent and Trademark Office. The USPTO has given the VSIQQ trademark a serial number of 79314850. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, June 1, 2022. This trademark is owned by NOVARTIS AG. The VSIQQ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
vsiqq

General Information


Serial Number79314850
Word MarkVSIQQ
Filing DateThursday, May 20, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, June 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, June 18, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 1, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 1, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 27, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, June 1, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, June 1, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 10, 2022ASSIGNED TO EXAMINER
Sunday, December 12, 2021REFUSAL PROCESSED BY IB
Thursday, November 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 18, 2021REFUSAL PROCESSED BY MPU
Friday, October 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 21, 2021NON-FINAL ACTION WRITTEN
Thursday, October 21, 2021NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, September 28, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 27, 2021NON-FINAL ACTION WRITTEN
Monday, September 20, 2021ASSIGNED TO EXAMINER
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 16, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 20, 2021APPLICATION FILING RECEIPT MAILED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB